OrbiMed’s Johnson & Johnson JNJ Stock Holding History

OrbiMed’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-414,100	Closed	-$57.2M	–	142
2018 Q3	$57.2M	Sell	414,100 -341,900	-45%	-$45.4M	0.69%	42
2018 Q2	$91.7M	Buy	756,000 +290,700	+62%	+$36.3M	1.09%	32
2018 Q1	$59.6M	Hold	465,300	–	–	0.74%	45
2017 Q4	$65M	Sell	465,300 -659,100	-59%	-$91.8M	0.82%	40
2017 Q3	$146M	Hold	1,124,400	–	–	1.4%	24
2017 Q2	$149M	Buy	1,124,400 +239,800	+27%	+$30.6M	1.56%	20
2017 Q1	$110M	Buy	884,600 +26,600	+3%	+$3.18M	1.25%	28
2016 Q4	$98.8M	Hold	858,000	–	–	1.26%	28
2016 Q3	$101M	Buy	858,000 +80,400	+10%	+$9.75M	1.15%	30
2016 Q2	$94.3M	Buy	777,600 +245,800	+46%	+$27.9M	0.98%	35
2016 Q1	$57.5M	Buy	531,800 +239,800	+82%	+$24.8M	0.61%	44
2015 Q4	$30M	Hold	292,000	–	–	0.27%	64
2015 Q3	$27.3M	Sell	292,000 -325,000	-53%	-$31.4M	0.28%	64
2015 Q2	$60.1M	Buy	617,000 +4,000	+0.7%	+$401K	0.5%	50
2015 Q1	$61.7M	Buy	613,000 +118,000	+24%	+$12M	0.53%	53
2014 Q4	$51.8M	Buy	495,000 +72,000	+17%	+$7.59M	0.49%	48
2014 Q3	$45.1M	Sell	423,000 -59,000	-12%	-$6.12M	0.47%	49
2014 Q2	$50.4M	Sell	482,000 -115,000	-19%	-$11.6M	0.59%	44
2014 Q1	$58.6M	Sell	597,000 -29,000	-5%	-$2.69M	0.72%	41
2013 Q4	$57.3M	Sell	626,000 -27,000	-4%	-$2.49M	0.84%	38
2013 Q3	$56.6M	Buy	653,000 +452,000	+225%	+$40.5M	1.01%	30
2013 Q2	$17.3M	Buy	+201,000	New	+$17.1M	0.37%	56

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

OrbiMed's JNJ Position: Q4 2018 in Review

OrbiMed sold out of Johnson & Johnson (JNJ) in Q4 2018, closing a stake of 414,100 shares — an estimated $57.2M sold.

OrbiMed first reported a position in JNJ in Q2 2013 and held it in 22 quarters. The position peaked at $149M in Q2 2017. 2,764 funds tracked by Wall St. Rank hold JNJ as of Q4 2018.

OrbiMed reported no remaining Johnson & Johnson position as of Q4 2018 after selling out during the quarter.
OrbiMed sold 414,100 Johnson & Johnson shares in Q4 2018, an estimated $57.2M.
OrbiMed first reported a position in Johnson & Johnson in Q2 2013 and held it in 22 quarters.
OrbiMed's Johnson & Johnson position peaked at $149M in Q2 2017.
2,764 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2018.

Based on OrbiMed's 13F filing for Q4 2018, filed 14 Feb 2019.